Cognex Corporation

Informe acción NasdaqGS:CGNX

Capitalización de mercado: US$10.8b

Cognex Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Cognex de 24.7% y 8.8% por año respectivamente. Se prevé que el BPA crezca en un 25.2% al año. Se espera que la rentabilidad financiera sea de 18.9% en 3 años.

Información clave

24.7%

Tasa de crecimiento de los beneficios

25.19%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Electronic26.1%
Tasa de crecimiento de los ingresos8.8%
Rentabilidad financiera futura18.89%
Cobertura de analistas

Good

Última actualización14 Jul 2026

Actualizaciones recientes sobre el crecimiento futuro

Artículo de análisis May 09

Cognex Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cognex Corporation ( NASDAQ:CGNX ) just released its quarterly report and things are looking bullish. The company beat...

Recent updates

Seeking Alpha Jul 07

Cognex: Quality Doesn't Come Cheap, With Momentum To Boot

Summary Cognex Corporation is a top U.S. machine vision leader, now trading at 4-year highs and outperforming peers and the broader market. CGNX's strategic pivot—expanding its customer base, and launching the OneVision cloud platform, positions it for accelerated 9-11% revenue CAGR through FY28 and as a key facilitator of industrial AI in the Western markets. EBITDA margins have surged, with Q1 at 26.9% (+1,000 bps YoY), and guidance points to further margin expansion (potentially closer to 32%) and sustained >100% FCF conversion. Despite premium valuations (EV/EBITDA ~37x and a sub-par FCF yield of 2%), I rate CGNX a buy, citing quality execution, margin progression, and strong technical momentum. Read the full article on Seeking Alpha
Actualización de narrativa Jul 02

CGNX: AI Vision Expansion And End Market Diversification Will Support Fair Outlook

Cognex's updated analyst price framework reflects a modest fair value lift to $64.14 from $61.65, with analysts tying higher targets, often in the $60s to mid $70s range, to AI enabled product progress, broader end market exposure, and more constructive views on revenue growth, margins, and future P/E assumptions. Analyst Commentary Recent Street research on Cognex highlights a mixed but generally constructive tone, with several firms lifting price targets and, in one case, upgrading the stock on the back of AI enabled vision systems, broader end market exposure, and sales model changes.
Artículo de análisis Jun 20

Cognex (CGNX) Stock Could Be 13.3% Undervalued After Zacks Rank Upgrade

Cognex (CGNX) has moved into focus after being added to the Zacks Rank #1 (Strong Buy) list, a shift driven by a higher consensus earnings estimate for its machine vision business. See our latest analysis for Cognex. Cognex’s recent earnings estimate upgrade and macro driven swings have come against a backdrop of strong share price momentum, with a 90 day share price return of 34.24% and a 1 year total shareholder return of 124.77%. This suggests recent optimism is building on an already...
Actualización de narrativa Jun 18

CGNX: AI Vision Expansion And Margin Execution Will Support Premium Stock Multiple

Analysts have raised the implied fair value for Cognex to $76.25 from $65.60, citing higher assumed revenue growth, stronger profit margins, and a series of recent price target increases related to AI-enabled vision systems and an expanding customer base. Analyst Commentary Recent research on Cognex points to a clear split between enthusiasm for the company’s AI-enabled vision systems and a more measured view on how quickly those strengths translate into sustained growth and returns.
Actualización de narrativa Jun 03

CGNX: AI Vision Turnaround And Cost Discipline Will Support Fairly Valued Outlook

Narrative Update: Cognex Analyst Price Target Move The analyst price target for Cognex is updated from $50.92 to $61.65, with analysts citing AI-enabled vision systems, a broader customer base, an improved mix, and expense leverage as key factors supporting higher fair value assumptions. Analyst Commentary Recent research updates around Cognex point to a more constructive tone on growth opportunities tied to AI enabled vision systems and a broader customer base, but there is still a pocket of caution that centers on how much of this optimism is already reflected in the stock price and how consistently the company can execute.
Actualización de narrativa May 19

CGNX: Margin Execution And Automation Demand Will Drive Future Share Upside

Analysts have lifted the updated price target framework for Cognex to $90.99 from $60.96, citing broad Street target increases. These changes reflect a more favorable organic growth outlook, stronger gross margin performance, and ongoing operating expense leverage.
Artículo de análisis May 09

Cognex Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cognex Corporation ( NASDAQ:CGNX ) just released its quarterly report and things are looking bullish. The company beat...
Actualización de narrativa Apr 28

CGNX: Margin Discipline And End Market Recovery Will Support Fairly Valued Outlook

Cognex's analyst price target has slipped slightly from about $52 to $50.92 as analysts balance a softer revenue growth outlook with firmer margin expectations and still elevated P/E assumptions. Analyst Commentary Recent research on Cognex shows a split view, with some firms lifting targets and ratings while others are taking a more restrained stance as they reassess growth, margins, and valuation after the latest earnings updates.
Actualización de narrativa Apr 14

CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Recovery

The analyst price target for Cognex has edged up by $0.10 to $65.60 as analysts highlight margin improvement efforts, cost reduction plans, and a recovering demand backdrop across key end markets. Analyst Commentary Recent research signals a generally constructive shift in sentiment on Cognex, with several banks lifting price targets and a few moving ratings higher as they reassess earnings power, margins, and the demand backdrop.
Actualización de narrativa Mar 31

CGNX: Margin Discipline And Buybacks Will Support Premium Multiple In Industrial Recovery

Analyst price targets on Cognex have moved higher, with the updated fair value estimate holding at $65.50. Analysts point to margin improvement, cost initiatives, a recovering short cycle industrial group, and steadier segment trends as key supports for the new targets.
Actualización de narrativa Mar 17

CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Industrial Recovery

Cognex's analyst fair value estimate has been revised higher from $60.55 to $65.50. Analysts highlight improving short cycle industrial demand, faster margin progress, cost reduction efforts, and a broader customer base, which support higher revenue growth assumptions and a richer future P/E of 44.37x versus 41.32x previously.
Actualización de narrativa Mar 02

CGNX: Margin Execution And Demand Stability Will Shape Fairly Valued Outlook

The analyst fair value estimate for Cognex has been raised from $36.62 to $52.00, reflecting higher Street price targets in the $55 to $75 range and analyst expectations for improved margins, cost control, and a more stable demand backdrop across key segments. Analyst Commentary Recent Street research on Cognex clusters around higher price targets and a more constructive stance on margins, cost controls, and demand stability, but the tone is not uniformly bullish.
Artículo de análisis Feb 19

We Like The Quality Of Cognex's (NASDAQ:CGNX) Earnings

Investors signalled that they were pleased with Cognex Corporation's ( NASDAQ:CGNX ) most recent earnings report. This...
Actualización de narrativa Feb 16

CGNX: Cost Discipline And Automation Demand Will Support Margins And Buybacks

Analysts have raised their price target on Cognex by about $11.90 to $60.55, citing updated assumptions around fair value, discount rate, revenue growth, profit margins, and future P/E multiples, which are in line with recent Street target increases from UBS, Barclays, and KeyBanc. Analyst Commentary Recent target changes around Cognex reflect a mix of optimism on long term demand drivers and some caution on execution and timing, with several firms adjusting their models as part of broader industrial technology outlooks for 2026.
Actualización de narrativa Feb 02

CGNX: Industrial Tech Tailwinds Will Face Stricter Execution And Margin Expectations

Analysts have trimmed their price target on Cognex to US$54, down US$2, as they refresh assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E in light of updated views on industrial technology demand across data centers, factory and warehouse automation, electronics, test and measurement, and semiconductors. Analyst Commentary Recent research trims the price target on Cognex to US$54, which signals that some expectations around future growth, margins, and valuation are being reset, even as broader industrial technology end markets such as data centers, factory automation, warehouse automation, electronics, test and measurement, and semiconductors are viewed constructively.
Actualización de narrativa Jan 19

CGNX: Cost Cuts And Automation Exposure Will Drive Future Share Upside

Analysts have trimmed their average price target for Cognex by about $2 to roughly $54, reflecting updated views on fair value, discount rate, growth, margins and future P/E after recent sector wide adjustments to industrial technology outlooks. Analyst Commentary Recent Street commentary around Cognex centers on small adjustments to fair value assumptions while keeping a generally constructive view on the company and its exposure to industrial technology end markets.
Actualización de narrativa Jan 05

CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins

Analysts have nudged their price target for Cognex slightly higher, reflecting a modest fair value increase to about $48.65 as they anticipate margin recovery and stronger 2025 EBITDA, supported by continued R&D investment and disciplined cost control. Analyst Commentary Bullish Takeaways Bullish analysts highlight expectations for a strong EBITDA recovery in 2025, supported by top line growth and disciplined expense management, which underpins the higher fair value range.
Actualización de narrativa Dec 21

CGNX: EBITDA Recovery And Cost Cuts Will Drive Strong Share Upside

Analysts have raised their price target on Cognex to a range centered around approximately $55, up from the prior mid $30s to low $40s range. They cite expectations for stronger revenue growth, higher profit margins, and a robust EBITDA recovery supported by disciplined expense management and sustained R&D investment.
Actualización de narrativa Dec 07

CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins And Earnings

Analysts have nudged their average price target on Cognex slightly higher, with recent moves such as a lift to about $45 and a bullish $55 initiation. These changes reflect expectations for a measured recovery in growth and margins, supported by stronger 2025 EBITDA and disciplined cost control.
Actualización de narrativa Nov 23

CGNX: Cost Reductions And Expense Discipline Will Drive Earnings Recovery In 2025

The analyst price target for Cognex has increased from $37 to $45. Analysts cite improved profit margins and expectations for stronger EBITDA recovery, driven by disciplined expense management and robust investments in R&D and sales.
Actualización de narrativa Nov 06

CGNX: Expense Discipline And Cost Cuts Will Drive Stronger Margins Ahead

The analyst price target for Cognex has increased from $48.25 to $48.90, as analysts note improving margin prospects beyond near-term tariff headwinds. They also anticipate strong EBITDA recovery driven by disciplined expense management and ongoing growth initiatives.
Actualización de narrativa Oct 23

Analysts Weigh Cognex Growth Outlook Amid Valuation Changes and Activist Investor Developments

Analysts have increased their fair value estimate for Cognex from $48.00 to $48.25. This change is attributed to improving demand trends and expectations of stronger future EBITDA margins.
Actualización de narrativa Oct 09

Cloud And AI Vision Solutions Will Expand Market Reach

The analyst fair value estimate for Cognex has been raised modestly from $47.21 to $48.00 per share. Analysts anticipate improved revenue growth and margin recovery, supported by disciplined cost management and ongoing investment in core strengths.
Actualización de narrativa Sep 25

Cloud And AI Vision Solutions Will Expand Market Reach

Analysts have raised their price target for Cognex to $47.21, citing improving end-market demand, stronger than expected operating leverage, and sector-wide optimism on earnings growth. Analyst Commentary Improving demand across most of Cognex's end markets is expected to drive a return to more normalized upcycle operating leverage into 2026.
Artículo de análisis Sep 21

When Should You Buy Cognex Corporation (NASDAQ:CGNX)?

While Cognex Corporation ( NASDAQ:CGNX ) might not have the largest market cap around , it led the NASDAQGS gainers...
Actualización de narrativa Sep 10

Cloud And AI Vision Solutions Will Expand Market Reach

Analysts have trimmed their price target for Cognex to $46.17 as near-term neutrality and only modest improvements outweigh longer-term optimism for margin expansion and demand recovery in 2026. Analyst Commentary Bullish analysts expect improving demand across most end markets to drive a return to normalized upcycle operating leverage by 2026.
Artículo de análisis Sep 03

A Look At The Intrinsic Value Of Cognex Corporation (NASDAQ:CGNX)

Key Insights Cognex's estimated fair value is US$46.24 based on 2 Stage Free Cash Flow to Equity Current share price of...
Artículo de análisis Aug 01

Why Investors Shouldn't Be Surprised By Cognex Corporation's (NASDAQ:CGNX) 27% Share Price Surge

Cognex Corporation ( NASDAQ:CGNX ) shares have continued their recent momentum with a 27% gain in the last month alone...
Artículo de análisis Jul 23

Cognex's (NASDAQ:CGNX) Returns Have Hit A Wall

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Seeking Alpha Mar 04

Cognex: Headwinds Likely To Persist In 2025

Summary Cognex's has come under pressure in recent months with ongoing demand weakness undermining investor confidence in the company. While Cognex has a bright future, macro headwinds seem set to persist in the near term and could increase as 2025 progresses. This could be problematic for Cognex's stock, as its valuation remains elevated, despite the recent pullback. Read the full article on Seeking Alpha

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:CGNX - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20281,3333533793589
12/31/20271,20728831631820
12/31/20261,10924027326920
4/5/20261,047143241250N/A
12/31/2025994114237246N/A
9/28/2025972110214222N/A
6/29/2025930122180191N/A
3/30/2025920118162176N/A
12/31/2024915106134149N/A
9/29/20248828992112N/A
6/30/2024844787597N/A
3/31/20248471007799N/A
12/31/202383811390113N/A
10/1/2023880157145165N/A
7/2/2023893172189207N/A
4/2/2023925174201221N/A
12/31/20221,006216224243N/A
10/2/20221,011214212232N/A
7/3/20221,086259193213N/A
4/3/20221,080277247265N/A
12/31/20211,037280299314N/A
10/3/20211,017296328342N/A
7/4/2021983304348361N/A
4/4/2021883226266279N/A
12/31/2020811176229242N/A
9/27/2020757187209227N/A
6/28/2020689141190209N/A
3/29/2020719191N/A254N/A
12/31/2019726204N/A253N/A
9/29/2019749169N/A257N/A
6/30/2019798208N/A271N/A
3/31/2019810215N/A230N/A
12/31/2018806219N/A223N/A
9/30/2018796146N/A236N/A
7/1/2018830168N/A206N/A
4/1/2018797168N/A231N/A
12/31/2017766177N/A224N/A
10/1/2017712243N/A215N/A
7/2/2017594194N/A223N/A
4/2/2017564180N/A202N/A
12/31/2016530144N/A182N/A
10/2/2016489130N/A151N/A
7/3/2016449103N/A160N/A
4/3/2016445103N/A152N/A
12/31/2015451108N/A128N/A
10/4/2015451111N/A177N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (24.7% al año) de CGNX es superior a la tasa de ahorro (3.5%).

Beneficios vs. Mercado: Se prevé que los beneficios (24.7% al año) de CGNX crezcan más rápidamente que el mercado US (18.1% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de CGNX crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (8.8% al año) de CGNX crezcan más despacio que el mercado de US (12.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 8.8% al año) de CGNX crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CGNX sea baja dentro de 3 años (18.9%).


Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/07/15 06:24
Precio de las acciones al final del día2026/07/15 00:00
Beneficios2026/04/05
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Cognex Corporation está cubierta por 37 analistas. 20 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Quinn FredricksonBaird
Robert MasonBaird
Guy HardwickBarclays